Self-antigen–specific CD8(+) T cell precursor frequency determines the quality of the antitumor immune response

A primary goal of cancer immunotherapy is to improve the naturally occurring, but weak, immune response to tumors. Ineffective responses to cancer vaccines may be caused, in part, by low numbers of self-reactive lymphocytes surviving negative selection. Here, we estimated the frequency of CD8(+) T c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzuto, Gabrielle A., Merghoub, Taha, Hirschhorn-Cymerman, Daniel, Liu, Cailian, Lesokhin, Alexander M., Sahawneh, Diana, Zhong, Hong, Panageas, Katherine S., Perales, Miguel-Angel, Altan-Bonnet, Grégoire, Wolchok, Jedd D., Houghton, Alan N.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715122/
https://www.ncbi.nlm.nih.gov/pubmed/19332877
http://dx.doi.org/10.1084/jem.20081382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715122/
https://www.ncbi.nlm.nih.gov/pubmed/19332877
http://dx.doi.org/10.1084/jem.20081382

Ejemplares similares